Citius Pharmaceuticals Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.78 |
Market Cap |
$22.09 M |
Shares Outstanding |
22.08 M |
Public Float |
8.08 M |
Address |
11 Commerce Drive Cranford New Jersey 07016 United States |
Employees | - |
Website | http://www.citiuspharma.com |
Updated | 07/08/2019 |
Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. Its products include Mino-Lok and hydrocortisone-lidocaine. The company was founded on September 09, 2010 and is headquartered in Cranford, NJ. |